Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Biosurveillance

    First U.S. MERS-CoV Patient to be Released from Hospital

    By Global Biodefense StaffMay 7, 2014
    Coronavirus
    Colorized transmission electron micrograph of the Middle East respiratory syndrome coronavirus. Credit: NIAID
    Share
    Facebook LinkedIn Reddit Email

    The man hospitalized in Indiana with the first U.S. case of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is improving and could be released from the hospital soon.

    Indiana State Department of Health Commissioner William VanNess II, Governor Mike Pence, and CDC and hospital officials updated the media on Monday, saying none of the more than 50 health-care workers and family members who’ve had contact with the patient have tested positive for the virus. MERS-CoV has an incubation period of up to 14 days.

    The infected patient had traveled by plane from Riyadh, Saudi Arabia to Chicago, Illinois on April 24, 2014.  He then traveled by bus from Chicago to Indiana. Several days later, he began to experience respiratory symptoms, including shortness of breath, coughing, and fever. He went to the emergency department on April 28th and was admitted on that same day.

    Health officials have reportedly contacted a large number of the passengers who traveled on the same flight or bus as the infected patient and none has reported symptoms of the coronavirus.

    At least 400 cases of MERS have been reported in the past two years, and more than 100 people have died.

    “In this interconnected world we live in, we expected MERS to make its way to the United States,” Dr. Tom Frieden, director of the CDC, said during press conference Friday. “We have been preparing since 2012 for this possibility.”

    Coronavirus Emerging Threats MERS-CoV
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleDistinct Avian Influenza Viruses Discovered In Antarctic Penguins
    Next Article Notable Contracts: Ricin Vaccine Award to GE Healthcare

    Related Stories

    The Basics on the Nipah Virus Outbreak in India

    September 19, 2023

    Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant

    September 17, 2023

    Case Study: Fatal Avian Influenza Infection in Cat in Poland

    September 15, 2023

    Bird Flu Undergoing Changes That Could Increase Risk of Widespread Human Transmission

    September 14, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    Oct 17
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Dispensing and Administration of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.